相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adamantane-Monoterpenoid Conjugates Linked via Heterocyclic Linkers Enhance the Cytotoxic Effect of Topotecan
Aldar A. Munkuev et al.
MOLECULES (2022)
In Vitro and In Silico Studies of Human Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) Inhibition by Stereoisomeric Forms of Lipophilic Nucleosides: The Role of Carbohydrate Stereochemistry in Ligand-Enzyme Interactions
Nadezhda S. Dyrkheeva et al.
MOLECULES (2022)
In vivo toxicological assessment of diquat dibromide: cytotoxic, genotoxic, and biochemical approach
Ali Acar
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2021)
The influence of an enamine usnic acid derivative (a tyrosyl-DNA phosphodiesterase 1 inhibitor) on the therapeutic effect of topotecan against transplanted tumors in vivo
V. P. Nikolin et al.
CLINICAL & EXPERIMENTAL METASTASIS (2021)
In vitro genotoxicity assessment of functional ingredients: DHA, rutin and α-tocopherol
Julen Sanz-Serrano et al.
FOOD AND CHEMICAL TOXICOLOGY (2021)
Promising New Inhibitors of Tyrosyl-DNA Phosphodiesterase I (Tdp 1) Combining 4-Arylcoumarin and Monoterpenoid Moieties as Components of Complex Antitumor Therapy
Tatyana M. Khomenko et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Design, Synthesis and Molecular Modeling Study of Conjugates of ADP and Morpholino Nucleosides as A Novel Class of Inhibitors of PARP-1, PARP-2 and PARP-3
Yuliya V. Sherstyuk et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Multifaceted Role of PARP-1 in DNA Repair and Inflammation: Pathological and Therapeutic Implications in Cancer and Non-Cancer Diseases
Simonetta Pazzaglia et al.
CELLS (2020)
Inhibition of Tyrosyl-DNA Phosphodiesterase 1 by Lipophilic Pyrimidine Nucleosides
Alexandra L. Zakharenko et al.
MOLECULES (2020)
Human Tyrosyl-DNA Phosphodiesterase 1 Possesses Transphosphooligonucleotidation Activity With Primary Alcohols
Nadezhda Dyrkheeva et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Dual DNA topoisomerase 1 and tyrosyl-DNA phosphodiesterase 1 inhibition for improved anticancer activity
Alexandra Zakharenko et al.
MEDICINAL RESEARCH REVIEWS (2019)
Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topotecan on in vivo tumor models
A. L. Zakharenko et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Topoisomerases as anticancer targets
Justine L. Delgado et al.
BIOCHEMICAL JOURNAL (2018)
Novel group of tyrosyl-DNA-phosphodiesterase 1 inhibitors based on disaccharide nucleosides as drug prototypes for anti-cancer therapy
Anastasia O. Komarova et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2018)
New tools in nucleoside toolbox of tick-borne encephalitis virus reproduction inhibitors
Alexey A. Orlov et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Modification of the length and structure of the linker of N6-benzyladenosine modulates its selective antiviral activity against enterovirus 71
Mikhail S. Drenichev et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Synthesis and biological evaluation of novel tyrosyl-DNA phosphodiesterase 1 inhibitors with a benzopentathiepine moiety
Alexandra Zakharenko et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2)
Yves Pommier et al.
DNA REPAIR (2014)
Regulation of multiple DNA repair pathways by the Fanconi anemia protein SLX4
Yonghwan Kim et al.
BLOOD (2013)
Synthesis of α-L-Threose Nucleoside Phosphonates via Regioselective Sugar Protection
Shrinivas G. Dumbre et al.
JOURNAL OF ORGANIC CHEMISTRY (2013)
DISACCHARIDE PYRIMIDINE NUCLEOSIDES AND THEIR DERIVATIVES: A NOVEL GROUP OF CELL-PENETRATING INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE 1
Anna S. Efremova et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2013)
Role of tyrosyl-DNA phosphodiesterase 1 and inter-players in regulation of tumor cell sensitivity to topoisomerase I inhibition
Paola Perego et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
Junko Murai et al.
CANCER RESEARCH (2012)
DNA Repair and Resistance to Topoisomerase I Inhibitors: Mechanisms, Biomarkers and Therapeutic Targets
M. Alagoz et al.
CURRENT MEDICINAL CHEMISTRY (2012)
The role of transporters in the toxicity of nucleoside and nucleotide analogs
Christopher A. Koczor et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2012)
One-Flow, Multistep Synthesis of Nucleosides by Bronsted Acid-Catalyzed Glycosylation
Adam Sniady et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
DNA Repair Factor MRE11/RAD50 Cleaves 3′-Phosphotyrosyl Bonds and Resects DNA to Repair Damage Caused by Topoisomerase 1 Poisons
Elizabeth J. Sacho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Poly(ADP-ribose) polymerase and XPF-ERCC1 participate in distinct pathways for the repair of topoisomerase I-induced DNA damage in mammalian cells
Yong-Wei Zhang et al.
NUCLEIC ACIDS RESEARCH (2011)
Review role of topotecan in gynaecological cancers: Current indications and perspectives
Domenica Lorusso et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2010)
Collaborative Action of Brca1 and CtIP in Elimination of Covalent Modifications from Double-Strand Breaks to Facilitate Subsequent Break Repair
Kyoko Nakamura et al.
PLOS GENETICS (2010)
Synergistic decrease of DNA single-strand break repair rates in mouse neural cells lacking both Tdp1 and aprataxin
Sherif F. El-Khamisy et al.
DNA REPAIR (2009)
Spinocerebellar ataxia with axonal neuropathy: consequence of a Tdp1 recessive neomorphic mutation?
Ryuki Hirano et al.
EMBO JOURNAL (2007)
TDP1 facilitates chromosomal single-strand break repair in neurons and is neuroprotective in vivo
Sachin Katyal et al.
EMBO JOURNAL (2007)
Mutation of a conserved active site residue converts Tyrosyl-DNA phosphodiesterase I in-to a DNA topoisomerase I-dependent poison
Xiaoping He et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Recent advances with topotecan in the treatment of lung cancer
Mary O'Brien et al.
ONCOLOGIST (2007)
Nucleoside transporters: from scavengers to novel therapeutic targets
Anne E. King et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
6-(2-alkylimidazol-1-yl)purines undergo regiospecific glycosylation at N9
MH Zhong et al.
ORGANIC LETTERS (2005)
'Green' methodology for efficient and selective benzoylation of nucleosides using benzoyl cyanide in an ionic liquid
AK Prasad et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
SCAN1 mutant Tdp1 accumulates the enzyme-DNA intermediate and causes camptothecin hypersensitivity
H Interthal et al.
EMBO JOURNAL (2005)
The comet assay for DNA damage and repair - Principles, applications, and limitations
AR Collins
MOLECULAR BIOTECHNOLOGY (2004)
Engineered resistance to camptothecin and antifolates by retroviral coexpression of tyrosyl DNA phosphodiesterase-I and thymidylate synthase
MC Nivens et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
TDP1 overexpression in human cells counteracts DNA damage mediated by topoisomerases I and II
HU Barthelmes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy
H Takashima et al.
NATURE GENETICS (2002)
分享论文
